Maintenance therapy with decitabine in younger adults with acute myeloid leukemia in first remission: a phase 2 Cancer and Leukemia Group B study (CALGB 10503)

In this prospective phase 2 clinical trial conducted by Cancer and Leukemia Group B (CALGB, now the Alliance), we studied decitabine as maintenance therapy for younger adults with acute myeloid leukemia (AML) who remained in first complete remission (CR1) following intensive induction and consolidat...

Descripción completa

Detalles Bibliográficos
Autores principales: Blum, William, Sanford, Ben L., Klisovic, Rebecca, DeAngelo, Daniel J., Uy, Geoffrey, Powell, Bayard L., Stock, Wendy, Baer, Maria R., Kolitz, Jonathan E., Wang, Eunice S., Hoke, Eva, Mrózek, Krzysztof, Kohlschmidt, Jessica, Bloomfield, Clara D., Geyer, Susan, Marcucci, Guido, Stone, Richard M., Larson, Richard A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5214595/
https://www.ncbi.nlm.nih.gov/pubmed/27624549
http://dx.doi.org/10.1038/leu.2016.252

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5214595/
https://www.ncbi.nlm.nih.gov/pubmed/27624549
http://dx.doi.org/10.1038/leu.2016.252

Ejemplares similares